Minnesota HF4034 modifies the Right to Try Act to allow patients with terminal or severely debilitating illnesses to access individualized.

Minnesota HF4034 modifies the Right to Try Act to allow patients with terminal or severely debilitating illnesses to access individualized investigational treatments. To qualify, patients must have exhausted all FDA-approved treatment options, received a physician's recommendation, and provided informed consent. Manufacturers may provide these treatments without compensation but can charge for manufacturing costs. The bill also ensures that health care providers are not penalized for participating in this process.

Minnesota HF4034 modifies the Right to Try Act to allow patients with terminal or severely debilitating illnesses to access individualized.

Minnesota HF4034 modifies the Right to Try Act to allow patients with terminal or severely debilitating illnesses to access individualized investigational treatments. To qualify, patients must have exhausted all FDA-approved treatment options, received a physician's recommendation, and provided informed consent. Manufacturers may provide these treatments without compensation but can charge for manufacturing costs. The bill also ensures that health care providers are not penalized for participating in this process.